Product Images Foscarnet Sodium

This is a formula to estimate the glomerular filtration rate (GFR) in adults based on age and serum creatinine levels. It calculates the GFR in mL/min/kg for males by multiplying the serum creatinine value by 72, and for females by multiplying by 0.85.*

This text provides information about the manufacturer and distributor of a product. The product is manufactured by Famneal, a division of Amneal Pharmaceuticals Pvt. Ltd. located in Mehsana, India. It is distributed by Amneal Pharmaceuticals LLC based in Bridgewater, NJ, 08807.*

This is a description of Foscarnet Sodium Injection solution labeled for central intravenous infusion. It requires dilution for peripheral intravenous infusion. The sterile solution contains 24 mg of Foscarnet Sodium per mL and is to be stored in controlled room temperature. It should be protected from heat and freezing. Administration should be done by controlled intravenous infusion, and precautions should be taken to dilute it properly for peripheral vein catheter administration. The usual dose information can be found in the package insert. Additionally, the solution needs to be discarded after single-use.*

This text is a detailed description of Foscarnet Sodium Injection, a medication for intravenous use. It provides information on dosage, administration precautions, storage, and manufacturer details. The medication should be diluted for peripheral intravenous infusion and must be administered by a controlled intravenous infusion. It emphasizes the importance of maintaining sterility during usage and storing it within a specified temperature range. Additionally, it provides guidance on the appropriate rate of infusion and dilution requirements.*

NDC 70121-1744-7 is a Foscarnet Sodium Injection available in 10 x 250 mL bags. This injection is meant for central intravenous infusion only and should be diluted for peripheral intravenous infusion. Each mL contains 24 mg Foscarnet Sodium, USP and is sterile and non-pyrogenic. The product should be stored between 20° to 25°C (68° to 77°F) and protected from excessive heat and freezing. The solution should be clear and colorless. Administer at a rate of no more than 1 mg/kg/minute and dilute to a 12 mg/mL concentration for peripheral vein catheter use. Consult the package insert for dosage and administration information. Refer to the attached sticker for Lot & Exp. information.*

This text is a product label for Foscarnet Sodium Injection in 12 x 250 mL bags, with each mL containing 24 mg of Foscarnet Sodium. It is intended for central intravenous infusion and must be diluted for peripheral intravenous infusion. The solution must be discarded if unused. The storage conditions are provided, and the precautions for administration are mentioned, including the maximum infusion rate and dilution instructions for peripheral vein catheter administration. The product is manufactured in India by Amneal Pharmaceuticals P Ltd. and distributed by Amneal Pharmaceuticals LLC in Bridgewater, NJ.*